The video head impluse test (vHIT) has become a standard and essential tool in modern vestibular diagnostics, widely used in clinics to evaluate the function of the semicircular canals and the vestibulo-ocular reflex (VOR)
[1-
3]. By tracking eye movements with a high-speed camera while the clinician performs quick, passive head rotations, vHIT provides a quantitative and non-invasive assessment of how well the vestibular system stabilizes gaze during motion
[4,
5] . It is particularly valuable for diagnosing peripheral vestibular disorders such as acute unilateral vestibulopathy, bilateral vestibulopathy, and Meniere's disease, as well as for distinguishing peripheral lesions from central causes of vertigo
[6,
7]. The test’s speed, portability, and ability to assess all six semicircular canals make it ideal for use in acute and outpatient settings, often serving as the first-line evaluation for patients presenting with dizziness or imbalance
[8].
The binocular video head impluse test is a new and emerging technology in clinical vestibular assessment, offering a promising evolution from the traditional monocular vHIT systems widely used today
[4,
9]. While standard vHIT devices record eye movements from a single eye, the binocular approach enables simultaneous measurement of both eyes, allowing clinicians to observe the symmetry and coordination of VOR responses with far greater precision
[10]. This innovation has only recently begun to enter clinical practice, but early research suggests it could significantly enhance diagnostic accuracy, particularly in identifying subtle disconjugacies and differentiating central from peripheral vestibular disorders
[11].
Determining whether acute vestibular symptoms arise from peripheral or non-peripheral (central or ocular motor) causes is a crucial early step that helps clinicians avoid missed diagnoses and misinterpretations
[7,
12]. Traditional monocular video head impluse testing (vHIT) is widely used in practice, but it may overlook important information when central pathways or extraocular muscles are affected, sometimes leading to results that resemble a peripheral lesion
[6,
9]. The study under discussion introduces a promising improvement: the binocular vHIT (B-vHIT), which measures differences between both eyes’ responses and uses a straightforward four-type classification system to help distinguish central or ocular motor causes from peripheral ones. The central concept shifts the focus from simply asking, “Is the gain low?” to a more insightful question: “Do both eyes tell the same story?”
1 What Was Done
The authors prospectively enrolled 104 from 248 patients presenting within 72 hours of acute vertigo and compared them with 46 healthy controls (20−40 years). Patients were assigned to peripheral vestibular vertigo (n = 71), central vertigo (n = 24), or peripheral ophthalmoplegia-related dizziness (n = 9) after standardized vestibular/neurologic exams and neuroimaging. Using a binocular system that records both eyes simultaneously across all six semicircular canals, they computed conventional VOR gains (pathologic thresholds: < 0.8 for horizontal canals, < 0.7 for vertical) and two binocular metrics: Inter-ocular Gain Asymmetry (percentage) and Inter-ocular Gain Difference (absolute difference). These feed a four-type readout.
2 What Stands Out
First, inter-ocular discordance strongly separates etiologies. A graded increase in Asymmetry and Difference was observed across groups, being lowest in controls, then peripheral, then central, and highest in ophthalmoplegia. Notably, Difference does not separate controls from peripheral disease, underscoring those large inter-ocular gaps are a non-peripheral warning sign rather than a marker of peripheral loss.
Second, realistic cut-offs work. ROC curves show excellent discrimination of non-peripheral vs. peripheral using Asymmetry (AUC 0.952) and especially Difference (AUC 0.967); the paper identifies 16% (Asymmetry) and 0.20 (Difference) as practical thresholds. For separating ophthalmoplegia from central vertigo, performance is modest but useful (Difference AUC 0.814, optimal threshold 0.37; Asymmetry AUC 0.763).
Third, a simple pattern map aligns with etiology. Type III (Gain+, Difference-)-reduced gain but preserved conjugacy-captured 70/71 peripheral cases (98.5% sensitivity, 90.9% specificity). In contrast, Types I and IV together identified non-peripheral etiologies with 79% sensitivity and 98.5% specificity. In practice: normal-normal (Type I) or both abnormal (Type IV) should push clinicians toward non-peripheral causes; low-gain-only (Type III) points to peripheral disease in most cases.
Fourth, the authors document important exceptions. Three non-peripheral cases presented as Type III (two infarcts-including vestibular nuclear territory-and one Miller-Fisher syndrome with near-complete ophthalmoplegia), reminding us that low gain alone is not "proof of periphery."
3 Why Binocular Metrics Help
The vestibulo-ocular reflex (VOR) is a conjugate, three-neuron system. Peripheral lesions primarily depress the afferent limb (hair cells/nerve), often reducing gains symmetrically across the two eyes for the affected canal pair. Central pathway injury (e.g., MLF, vestibular nuclei/cerebellum) and extraocular muscle or cranial-nerve palsies perturb the efferent limb or mechanics, producing disconjugacy-precisely what Difference detects and what monocular devices can miss. The graded increase in binocular discordance, evolving from peripheral through central to ophthalmoplegic involvement, parallels the hierarchical disruption of the VOR pathway and provides a physiological basis for the high discriminative power demonstrated in the ROC analysis.
Consider a one-line triage rule:
If Difference ≥ 0.20 (with or without low gain), favor non-peripheral and escalate neurologic evaluation-even when early MRI is unrevealing.
If Gain is reduced but Difference < 0.20 (Type III), a peripheral working diagnosis is reasonable, while staying alert to red flags.
If both Gain and Difference are normal (Type I) in the setting of acute vestibular syndrome, do not be reassured-this pattern clustered with non-peripheral disease in the cohort, echoing the classic HINTS insight that a normal impulse can be central.
4 Strengths
The study reflects the real-world diagnostic window within 72 hours of a single onset and uses binocular acquisition across all six canals. Crucially, it includes an ophthalmoplegia group, often overlooked in vertigo series, and demonstrates that B-vHIT uncovers the disconjugacy signal that distinguishes these patients from both peripheral and other central etiologies. The four-type readout and device-agnostic cut-offs (16%, 0.20) are easy to communicate across ED, neurology, and ENT services.
5 Limitations and Next Steps
Controls were young adults (20−40 years), whereas central causes in practice skew older; normative ranges and thresholds need validation in older cohorts and across emergency settings. The non-peripheral groups were small and heterogeneous (e.g., varied brainstem/cerebellar loci; mixed ophthalmoplegia etiologies), so lesion-specific performance is still uncertain. All tests were performed on a single binocular platform by one experienced operator; cross-vendor calibration and multicenter operator variability should be addressed.
VOR dysconjugacy arises from efferent—not afferent—dysfunction, and only a subset of central vestibular lesions disrupt these output pathways sufficiently to produce measurable disconjugacy. As such, B-vHIT is not a universal detector of central vestibulopathy and should not be viewed as a standalone diagnostic test. It cannot replace careful clinical history, focused neurologic examination, or appropriate neuroimaging. Instead, it may serve as a rapid, physiologically grounded adjunct—particularly useful for early triage when standard workup is still underway or when imaging is initially unrevealing.
Finally, while the proposed cut-offs and four-type classification scheme performed well in this cohort, their broader applicability remains to be confirmed. Larger, more age-diverse samples and prospective multicenter studies will be needed to validate these thresholds across platforms and clinical contexts before integration into routine workflows. Future directions include prospective multicenter studies, patient cohorts with precisely localized lesions, and serial B-vHIT assessments to monitor recovery and neural adaptation
6 Bottom Line
This paper usefully reframes vHIT from a monocular “gain test” to a binocular pattern detector. Two simple numbers-Asymmetry and especially Difference-capture whether the eyes are conjugate; the four-type schema then translates physiology into a bedside decision aid. In this cohort, Type III aligned tightly with peripheral disease, while Type I/IV flagged non-peripheral pathology with excellent specificity. With external validation and implementation work, B-vHIT could become a routine adjunct in acute vertigo pathways-improving triage, sharpening consultations, and helping clinicians avoid both false reassurance and unnecessary admissions.
The Author(s). This article is published by Higher Education Press at journal.hep.com.cn.
This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
PDF
(185KB)
